{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-223659","form_type":"8-K","ticker":"APLS","cik":"0001492422","company_name":"Apellis Pharmaceuticals, Inc.","filed_at":"2021-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.255974+00:00","generated_at":"2026-06-30T02:33:46.102968+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Apellis closes exchange of $201.1M convertible notes for 5.99M common shares","bullets":["Exchanged $201.1M principal of 3.500% Convertible Senior Notes due 2026 for 5,992,217 common shares.","After exchange, approximately $192.7M principal amount of Notes remain outstanding with third parties.","Transaction closed on July 23, 2021; shares issued are unregistered and restricted.","Privately negotiated exchange reduces debt and dilutes existing equity by ~3% based on prior share count."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-223659","json":"https://secwatch.observer/filing/0001193125-21-223659.json","markdown":"https://secwatch.observer/filing/0001193125-21-223659.md","text":"https://secwatch.observer/filing/0001193125-21-223659.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1492422/000119312521223659/0001193125-21-223659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1492422/000119312521223659/d217083d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T02:33:46.102968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}